CReATE-Sheneen-Daniels
Sheneen Garland Daniels, Ph.D.

Director of Clinical Division, Owner

Dr. Sheneen Daniels is the Director of the Clinical Division for CReATE, managing all clinical, administrative, programmatic, supervision, and training for a team of doctoral-level psychologists, graduate students, and other clinicians. She is a licensed psychologist with over 15 years experience in the assessment, diagnosis, and treatment of mental health and neurodevelopmental disorders and conditions, having conducted and supervised thousands of comprehensive psychological, psychoeducational, and neurocognitive evaluations. Dr. Daniels received her M.A. in Clinical Psychology from Western Carolina University and her Ph.D. from the University of Alabama. She completed her APA-approved doctoral internship at LSU Health Sciences Center in New Orleans. Dr. Daniels currently holds a position as Clinical Assistant Professor in the Department of Psychiatry at The University of North Carolina at Chapel Hill, with primary duties as Consulting Psychologist to the UNC TEACCH Autism Program (Asheville Center) and is the former interim director. Specializing in data-driven evaluation and treatment, Dr. Daniels’ clinical and research focus includes the assessment, identification, and treatment of autism spectrum disorders (ASD), learning disabilities(LD), ADHD, and other neurodevelopmental disorders; and the impact these conditions can have on an individual’s social, emotional, and behavioral functioning. Dr. Daniels has conducted psychological evaluations in numerous inpatient and outpatient clinical settings including hospitals, residential treatment centers, public and private schools, therapeutic boarding schools, university-based treatment centers, private practice, and wilderness therapy programs. In 2007, Drs. Daniels and Lewis founded CReATE, a unique private practice specializing in the provision of evidenced-based evaluations and the implementation of applied clinical research. Dr. Daniels was the co-investigator on two longitudinal, multi-site treatment outcome studies conducted through CReATE. She has presented widely on topics related to the identification, assessment, and treatment of neurodevelopmental disorders.